Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Valeant Pharmaceuticals International Inc. (T.BHC) had Income from Continuous Operations of 167.72M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
219.44M |
|
-- |
|
-- |
|
-- |
|
2.53B |
|
-- |
|
512.96M |
|
512.96M |
|
167.72M |
|
|
Income from Continuous Operations |
167.72M |
167.72M |
|
167.72M |
|
2.53B |
|
4.35B |
|
370.90M |
|
375.00M |
|
0.59 |
|
0.58 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.85B |
|
-- |
|
-- |
|
-- |
|
36.32B |
|
526.93M |
|
-21.72B |
|
526.93M |
|
370.53M |
|
| Cash Flow Statement Financials | |
1.96B |
|
-831.63M |
|
-1.04B |
|
1.68B |
|
1.85B |
|
173.31M |
|
301.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
0.98 |
|
55.31 |
|
70.65% |
|
17.66% |
|
17.66% |
|
30.34% |
|
3.57% |
|
1.53% |
|
1.40B |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
1.85 |
|
4.37 |
|
83.59 |
|
31.83% |
|
-0.77% |
|
0.46% |
|
0.57% |
|
1.42 |
|
3.74 |
|
5.22 |
|